Vainio et al196 observed that PLA2G7 overexpression was present in a majority of clinical prostate tumors and correlated positively (r = 0.66, P < .001) with the expression of ERG, an E twenty‐six gene (ETS)‐related gene that may be involved in the initiation and progression of prostate cancer. Here, PLA2G7 is linked to prostate carcinoma.